Please login to the form below

Not currently logged in
Email:
Password:

Optimum wins Silence Therapeutics account

The healthcare communications group will advise in financial PR

OptimumLondon, UK-based Optimum Strategic Communications has been appointed by RNAi-focused Silence Therapeutics.

Working with US strategic partner Burns McClellan, the healthcare communications group will develop and implement an investor relations and corporate communications programme for Silence Therapeutics.

Commenting on the appointments, Ali Mortazavi, chief executive officer of Silence Therapeutics, said:  “We wanted to work with a partner that could help us raise our profile in global investment community and build our reputation in the global life science industry.

“With its market-leading media relations expertise and unrivalled investor relations contacts, Optimum is the ideal partner to help us communicate our compelling equity story to the right healthcare investors.”

Since its launch in October 2017, Optimum has won over 20 clients in the life science and healthcare sectors.

Mary Clark, managing director of Optimum, said: “This is an exceptionally exciting time for Optimum and we are very excited to be working with Silence Therapeutics, which joins our growing client list of innovative and ambitious healthcare companies in the UK and across Europe.

“Our team’s knowledge of the global healthcare industry, combined with our understanding of the investor universe, enables us to provide our clients with an integrated service to help them achieve their goals.”

Article by
Gemma Jones

8th March 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics